Divi’s Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company’s board declared a dividend of Rs 30 per share and its Unit III greenfield project has commenced commercial operations.
Investors must moderate return expectations, stick to asset allocation: Nilesh Shah
Nilesh Shah of Kotak AMC remains optimistic about consumer discretionary spending, citing tax rebates, reduced EMI burdens, and the upcoming 8th Pay Commission. He favors
June 30, 2025